No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
PGNY240621C40000
- 0.07
- -0.43-86.00%
15min DelayClose May 31 15:59 ET
0.07High0.07Low
0.07Open0.50Pre Close1 Volume13 Open Interest40.00Strike Price7.00Turnover88.97%IV48.68%PremiumJun 21, 2024Expiry Date0.00Intrinsic Value100Multiplier19DDays to Expiry0.07Time Value100Contract SizeAmericanOptions Type0.0345Delta0.0139Gamma385.00Leverage Ratio-0.0107Theta0.0005Rho13.30Eff Leverage0.0047Vega
Intraday
- 5D
- 1D
News
Progyny's (NASDAQ:PGNY) Performance Is Even Better Than Its Earnings Suggest
Investors were underwhelmed by the solid earnings posted by Progyny, Inc. (NASDAQ:PGNY) recently. We did some digging and actually think they are being unnecessarily pessimistic. NasdaqGS:PGNY Ear
Progyny:Bd of Directors Approved Shr Repurchase Up to $100M of Common Stk, Follows Program Announced Feb 29 >PGNY
Progyny:Bd of Directors Approved Shr Repurchase Up to $100M of Common Stk, Follows Program Announced Feb 29 >PGNY
Express News | Progyny Announces $100M Share Repurchase Program Approved By Board Of Directors; To Be Funded Through Available Cash Balances
Express News | Progyny Announces $100M Stock Repurchase Program
Express News | Progyny Inc - Approved a Share Repurchase Program to Repurchase up to $100 Mln of Its Common Stock
Express News | Progyny, Inc. Announces Additional Share Repurchase Program
Comments
Progyny's CEO, Pete Anevski, is thrilled about the executive team expansion, confident that the new members' expertise will boost the company's growth in fertility, family building, and women's health benefits. Both Higgins and Leist are excited to contribute to Progyny's growth and innovation.
Press Release: Progyny Expands Its Leadership TeamInvestors may be justifying Progyny's high P/E ratio by betting on its potential to outperform market growth. The company's strong forecast growth is believed to be upholding its high P/E and providing strong support to its share price.
Progyny, with a low ROCE score of 9.2%, underscores promising fundamentals following its foray into profitability. Having offered a notable 27% to shareholders over three years, its developing factors necessitate a deeper analysis for future investment opportunities.
$Progyny(PGNY.US$ Bought in at 64.40 and now what do I do sigh
6
3
$Costco(COST.US$ Costco (COST) target raised by Citigroup from $460 to $495 at Neutral. Stock currently around $448
$Etsy Inc(ETSY.US$ Etsy (ETSY) target raised by Loop Capital from $220 to $245 at Buy. Stock currently around $211
$Generac(GNRC.US$ Generac (GNRC) target raised by Roth Capital from $480 to $500 at Buy. Stock currently around $425
$Fortinet(FTNT.US$ Fortinet (FTNT) target raised by Cowen from $335 to $385 at Outperform. Stock currently around $288
$NVIDIA(NVDA.US$ NVIDIA (NVDA) target raised by Susquehanna from $220 to $250 at Positive. Stock currently around $206
$Progyny(PGNY.US$ Progyny (PGNY) target raiosed by Barclays from $72 to $80 at Overweight. Stock currently around $56
$Etsy Inc(ETSY.US$ Etsy (ETSY) target raised by Loop Capital from $220 to $245 at Buy. Stock currently around $211
$Generac(GNRC.US$ Generac (GNRC) target raised by Roth Capital from $480 to $500 at Buy. Stock currently around $425
$Fortinet(FTNT.US$ Fortinet (FTNT) target raised by Cowen from $335 to $385 at Outperform. Stock currently around $288
$NVIDIA(NVDA.US$ NVIDIA (NVDA) target raised by Susquehanna from $220 to $250 at Positive. Stock currently around $206
$Progyny(PGNY.US$ Progyny (PGNY) target raiosed by Barclays from $72 to $80 at Overweight. Stock currently around $56
3
Read more